China's NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For ...

Retrieved on: 2021-02-08 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

China's NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For .... View article details on hiswai:

Excerpt

The above-mentioned Class III medical device is based on AnPac Bio's novel cancer differentiation analysis (CDA) technology and has been used in ...

Article found on: www.globenewswire.com